Biomarkers in acute cardiac disease.

[1]  Gregg Husk,et al.  A model for troponin I as a quantitative predictor of in-hospital mortality. , 2006, Journal of the American College of Cardiology.

[2]  Håkan Ahlström,et al.  Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. , 2006, Journal of the American College of Cardiology.

[3]  Fred S Apple,et al.  Biomarkers in acute cardiac disease: the present and the future. , 2006, Journal of the American College of Cardiology.

[4]  A. Jaffe,et al.  Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. , 2006, Clinical chemistry.

[5]  F. Apple,et al.  Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. , 2005, Clinical chemistry.

[6]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[7]  R. Califf,et al.  Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues. , 2004, Circulation.

[8]  Charles Weissman,et al.  Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. , 2003, Journal of the American College of Cardiology.

[9]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[10]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[11]  E. Topol,et al.  Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. , 1995, Circulation.